NAP-2 Secreted by Human NK Cells Can Stimulate Mesenchymal Stem/Stromal Cell Recruitment

Stem Cell Reports

Volumn 6, Issue 4, 2016, Pages 466-473

  Almeida, Catarina R ^a,b   Caires, Hugo R ^a,b,c   Vasconcelos, Daniela P ^a,b,c   Barbosa, Mário A ^a,b,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 BROMOPHENYL) 3 (2 HYDROXY 4 NITROPHENYL)UREA; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR7; CXCL3 CHEMOKINE; INTERLEUKIN 8; RANTES; BETA THROMBOGLOBULIN; CARBANILAMIDE DERIVATIVE; CONDITIONED MEDIUM; PPBP PROTEIN, HUMAN;

ARTICLE; BONE MARROW; CELL INVASION; CELL ISOLATION; CELL MIGRATION; CELL POPULATION; COCULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MESENCHYMAL STEM CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEIN SECRETION; TISSUE REPAIR; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; BONE MARROW CELL; CELL CULTURE; CELL MOTION; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECTS; MESENCHYMAL STROMA CELL; METABOLISM; SECRETION (PROCESS);

BETA-THROMBOGLOBULIN; BONE MARROW CELLS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL5; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; KILLER CELLS, NATURAL; MESENCHYMAL STROMAL CELLS; MODELS, BIOLOGICAL; PHENYLUREA COMPOUNDS; RECEPTORS, INTERLEUKIN-8B;

EID: 84963677396     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2016.02.012     Document Type: Article

References (36)

1. A.D. Agaiby, and M. Dyson Immuno-inflammatory cell dynamics during cutaneous wound healing J. Anat. 195 1999 531 542
2. C.R. Almeida, and D.M. Davis Segregation of HLA-C from ICAM-1 at NK cell immune synapses is controlled by its cell surface density J. Immunol. 177 2006 6904 6910
3. C.R. Almeida, A. Ashkenazi, G. Shahaf, D. Kaplan, D. Davis, and R. Mehr Human NK cells differ more in their KIR2DL1-dependent thresholds for HLA-Cw6-mediated inhibition than in their maximal killing capacity PLoS One 6 2011 e24927
4. C.R. Almeida, D.P. Vasconcelos, R.M. Gonçalves, and M.A. Barbosa Enhanced mesenchymal stromal cell recruitment via natural killer cells by incorporation of inflammatory signals in biomaterials J. R. Soc. Interf. 9 2012 261 271
5. K. Anton, D. Banerjee, and J. Glod Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion PLoS One 7 2012 e35036
6. G. Brooke, H. Tong, J.P. Levesque, and K. Atkinson Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta Stem Cells Dev. 17 2008 929 940
7. C.M. Champagne, J. Takebe, S. Offenbacher, and L.F. Cooper Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2 Bone 30 2002 26 31
8. M.A. Cooper, T.A. Fehniger, A. Ponnappan, V. Mehta, M.D. Wewers, and M.A. Caligiuri Interleukin-1beta costimulates interferon-gamma production by human natural killer cells Eur. J. Immunol. 31 2001 792 801
9. J. Croitoru-Lamoury, F.M. Lamoury, J.J. Zaunders, L.A. Veas, and B.J. Brew Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone J. Interferon Cytokine Res. 27 2007 53 64
10. F. Djouad, B. Delorme, M. Maurice, C. Bony, F. Apparailly, P. Louis-Plence, F. Canovas, P. Charbord, D. Noel, and C. Jorgensen Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes Arthritis Res. Ther. 9 2007 R33
11. K. Ekstrom, O. Omar, C. Graneli, X. Wang, F. Vazirisani, and P. Thomsen Monocyte exosomes stimulate the osteogenic gene expression of mesenchymal stem cells PLoS One 8 2013 e75227
12. J. Endt, F.E. McCann, C.R. Almeida, D. Urlaub, R. Leung, D. Pende, D.M. Davis, and C. Watzl Inhibitory receptor signals suppress ligation-induced recruitment of NKG2D to GM1-rich membrane domains at the human NK cell immune synapse J. Immunol. 178 2007 5606 5611
13. O.I. Eseonu, and C. De Bari Homing of mesenchymal stem cells: mechanistic or stochastic? Implications for targeted delivery in arthritis Rheumatology (Oxford) 54 2015 210 218
14. C. Fauriat, E.O. Long, H.-G. Ljunggren, and Y.T. Bryceson Regulation of human NK-cell cytokine and chemokine production by target cell recognition Blood 115 2010 2167 2176
15. F. Granero-Molto, J.A. Weis, M.I. Miga, B. Landis, T.J. Myers, L. O'Rear, L. Longobardi, E.D. Jansen, D.P. Mortlock, and A. Spagnoli Regenerative effects of transplanted mesenchymal stem cells in fracture healing Stem Cells 27 2009 1887 1898
16. H. Hemeda, M. Jakob, A.K. Ludwig, B. Giebel, S. Lang, and S. Brandau Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells Stem Cells Dev. 19 2010 693 706
17. M. Honczarenko, Y. Le, M. Swierkowski, I. Ghiran, A.M. Glodek, and L.E. Silberstein Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors Stem Cells 24 2006 1030 1041
18. G. Kalwitz, M. Endres, K. Neumann, K. Skriner, J. Ringe, O. Sezer, M. Sittinger, T. Häupl, and C. Kaps Gene expression profile of adult human bone marrow-derived mesenchymal stem cells stimulated by the chemokine CXCL7 Int. J. Biochem. Cell Biol. 41 2009 649 658
19. A. Kaplan, S. Kotzer, C.R. Almeida, R. Kohen, G. Halpert, M. Salmon-Divon, K. Kohler, P. Hoglund, D.M. Davis, and R. Mehr Simulations of the NK cell immune synapse reveal that activation thresholds can be established by inhibitory receptors acting locally J. Immunol. 187 2011 760 773
20. S. Kumar, and S. Ponnazhagan Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defect Bone 50 2012 1012 1018
21. J. Lee, S.H. Lee, N. Shin, M. Jeong, M.S. Kim, M.J. Kim, S.R. Yoon, J.W. Chung, T.D. Kim, and I. Choi Tumor necrosis factor-alpha enhances IL-15-induced natural killer cell differentiation Biochem. Biophys. Res. Commun. 386 2009 718 723
22. J. Liippo, M. Toriseva, and V.-M. Kähäri Natural killer cell in wound healing M. Lotze, A. Thomson, Natural Killer Cells - Basic Science and Clinical Application 2009 Academic Press 519 525
23. A. Moffett, and F. Colucci Uterine NK cells: active regulators at the maternal-fetal interface J. Clin. Invest. 124 2014 1872 1879
24. E. Nolte-'t Hoen, C. Almeida, N. Cohen, S. Nedvetzki, H. Yarwood, and D. Davis Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication Blood 109 2006 670 673
25. S.T. Passos, J.S. Silver, A.C. O'Hara, D. Sehy, J.S. Stumhofer, and C.A. Hunter Il-6 promotes NK cell production of IL-17 during toxoplasmosis J. Immunol. 184 2010 1776 1783
26. G. Pattappa, M. Peroglio, D. Sakai, J. Mochida, L.M. Benneker, M. Alini, and S. Grad CCL5/RANTES is a key chemoattractant released by degenerative intervertebral discs in organ culture Eur. Cell. Mater. 27 2014 124 136 discussion 136
27. A.L. Ponte, E. Marais, N. Gallay, A. Langonne, B. Delorme, O. Herault, P. Charbord, and J. Domenech The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities Stem Cells 25 2007 1737 1745
28. G. Ren, X. Zhao, L. Zhang, J. Zhang, A. L'Huillier, W. Ling, A.I. Roberts, A.D. Le, S. Shi, C. Shao, and et al. Inflammatory cytokine-induced intercellular adhesion Molecule-1 and vascular cell adhesion Molecule-1 in mesenchymal stem cells are critical for immunosuppression J. Immunol. 184 2010 2321 2328
29. J. Ringe, S. Strassburg, K. Neumann, M. Endres, M. Notter, G.R. Burmester, C. Kaps, and M. Sittinger Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2 J. Cell. Biochem. 101 2007 135 146
30. M.J. Robertson Role of chemokines in the biology of natural killer cells J. Leukoc. Biol. 71 2002 173 183
31. N.G. Singer, and A.I. Caplan Mesenchymal stem cells: mechanisms of inflammation Annu. Rev. Pathol. 6 2011 457 478
32. K. Soderstrom, E. Stein, P. Colmenero, U. Purath, U. Muller-Ladner, C.T. de Matos, I.H. Tarner, W.H. Robinson, and E.G. Engleman Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis Proc. Natl. Acad. Sci. USA 107 2010 13028 13033
33. V. Sordi, M.L. Malosio, F. Marchesi, A. Mercalli, R. Melzi, T. Giordano, N. Belmonte, G. Ferrari, B.E. Leone, F. Bertuzzi, and et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets Blood 106 2005 419 427
34. T. Tondreau, N. Meuleman, B. Stamatopoulos, C. De Bruyn, A. Delforge, M. Dejeneffe, P. Martiat, D. Bron, and L. Lagneaux In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues Cytotherapy 11 2009 559 569
35. F. Vianello, I.T. Olszak, and M.C. Poznansky Fugetaxis: active movement of leukocytes away from a chemokinetic agent J. Mol. Med. (Berl) 83 2005 752 763
36. X. Wei, X. Yang, Z.P. Han, F.F. Qu, L. Shao, and Y.F. Shi Mesenchymal stem cells: a new trend for cell therapy Acta Pharmacol. Sin. 34 2013 747 754